Ethics and Plagiarism

The use of texts or ideas from other sources without proper credit is not accepted. All sources used in the manuscript must be fully disclosed.

To use images from other sources, it is necessary to obtain explicit permission from the copyright holder.

JAFF uses the CopySpider® and Similarity Check® plagiarism detection software to identify similarities, which are analyzed on a case-by-case basis.

The editors and the Editorial Board are responsible for upholding the ethical standards of the Journal of Pharmaceutical Assistance and Pharmacoeconomics and must resolve any conflicts transparently, always aiming to maintain the journal’s credibility. Transparency and quality control are aspects of the editorial process that fall under the responsibility of the Editor-in-Chief.

Conduct in Cases of Suspected Ethical Violations

The following are considered ethical violations: plagiarism, duplicate publication, data fabrication, authorship issues (e.g., changes, ghost authorship), undisclosed conflicts of interest, misappropriation of ideas or data by reviewers, and other ethical concerns related to research.

The recommendations of the Committee on Publication Ethics (COPE) https://publicationethics.org/guidance will be followed in cases of suspected ethical violations.

In cases of suspected ethical misconduct, it may be necessary for the Editor to request study data from the author(s) for inspection or verification. The Editor may reject a manuscript and contact, for example, the author's institution(s) and ethics committee(s). Any concerns regarding data integrity raised during or after the peer review process will be referred to the Editor.

For published papers in which misconduct is identified, a retraction will be issued, including in the document the reason for the retraction with proper reference, upon notification by the author or the editor. Cases involving errors or failures that do not constitute misconduct will be corrected through an erratum.